Sandy Spring Bank’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$183 Hold
2
﹤0.01% 1168
2024
Q4
$228 Hold
2
﹤0.01% 1166
2024
Q3
$238 Sell
2
-3
-60% -$276 ﹤0.01% 1147
2024
Q2
$403 Sell
5
-69
-93% -$6.31K ﹤0.01% 1192
2024
Q1
$6.83K Hold
74
﹤0.01% 915
2023
Q4
$7.81K Hold
74
﹤0.01% 858
2023
Q3
$8.04K Hold
74
﹤0.01% 852
2023
Q2
$7.99K Hold
74
﹤0.01% 883
2023
Q1
$9.22K Hold
74
﹤0.01% 839
2022
Q4
$11.1K Sell
74
-39
-35% -$6K ﹤0.01% 802
2022
Q3
$15K Hold
113
﹤0.01% 722
2022
Q2
$17K Hold
113
﹤0.01% 724
2022
Q1
$19K Hold
113
﹤0.01% 716
2021
Q4
$29K Buy
113
+11
+11% +$3.01K ﹤0.01% 682
2021
Q3
$28K Hold
102
﹤0.01% 687
2021
Q2
$23K Hold
102
﹤0.01% 743
2021
Q1
$11K Hold
102
﹤0.01% 770
2020
Q4
$8K Buy
+102
New +$10K ﹤0.01% 770

Other funds holding BNTX

Sandy Spring Bank's BNTX Position: Q1 2025 in Review

Sandy Spring Bank held its BioNTech (BNTX) position steady in Q1 2025 at 2 shares worth $183. The position accounts for ﹤0.01% of the portfolio, ranked #1168.

Sandy Spring Bank first reported a position in BNTX in Q4 2020 and has held it in 18 quarters since. The position peaked at $29K in Q4 2021. 280 funds tracked by Wall St. Rank hold BNTX as of Q1 2025.

  • Sandy Spring Bank held 2 shares of BioNTech worth $183 as of Q1 2025.
  • Sandy Spring Bank left its BioNTech share count unchanged in Q1 2025.
  • BioNTech made up ﹤0.01% of Sandy Spring Bank's portfolio in Q1 2025, its #1168 holding.
  • Sandy Spring Bank first reported a position in BioNTech in Q4 2020 and has held it in 18 quarters since.
  • Sandy Spring Bank's BioNTech position peaked at $29K in Q4 2021.
  • 280 funds tracked by Wall St. Rank held BioNTech as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.